Bleeding complications during cardiac electronic device implantation in patients receiving antithrombotic therapy: is there any value of local tranexamic acid?

BACKGROUND: The perioperative use of antithrombotic therapy is associated with increased bleeding risk after cardiac implantable electronic device (CIED) implantation. Topical application of tranexamic acid (TXA) is effective in reducing bleeding complications after various surgical operations. Howe...

Descripción completa

Detalles Bibliográficos
Autores principales: Beton, Osman, Saricam, Ersin, Kaya, Hakki, Yucel, Hasan, Dogdu, Orhan, Turgut, Okan Onur, Berkan, Ocal, Tandogan, Izzet, Yilmaz, Mehmet Birhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841978/
https://www.ncbi.nlm.nih.gov/pubmed/27105588
http://dx.doi.org/10.1186/s12872-016-0251-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841978/
https://www.ncbi.nlm.nih.gov/pubmed/27105588
http://dx.doi.org/10.1186/s12872-016-0251-1

Ejemplares similares